PT  - JOURNAL ARTICLE
AU  - Kim, Luke D.
AU  - Factora, Ronan M.
TI  - Alzheimer dementia: Starting, stopping drug therapy
AID  - 10.3949/ccjm.85a.16080
DP  - 2018 Mar 01
TA  - Cleveland Clinic Journal of Medicine
PG  - 209--214
VI  - 85
IP  - 3
4099  - http://www.ccjm.org/content/85/3/209.short
4100  - http://www.ccjm.org/content/85/3/209.full
SO  - Cleve Clin J Med2018 Mar 01; 85
AB  - Alzheimer disease is the most common type of dementia. Two classes of cognition-enhancing drugs are approved to treat the symptoms, and both have provided modest benefit in clinical trials. Psychotropic drugs are sometimes used off-label to treat behavioral symptoms of Alzheimer disease. All these medications should be continuously evaluated for clinical efficacy and, when appropriate, discontinued if the primary benefit—preservation of cognitive and functional status and a reduction in behaviors associated with dementia—is no longer being achieved.